Condition
Opioid Induced Respiratory Depression
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
P 1 (2)
Trial Status
Recruiting1
Unknown1
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05338632Phase 1TerminatedPrimary
Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists
NCT07227389Recruiting
Timing of Opioid Administration and Postoperative Respiratory Depression.
NCT05730062Phase 1UnknownPrimary
Influence of Oxycodone on Individuals Taking an SSRI
NCT01860885CompletedPrimary
Critical Respiratory Events in Children Requiring Naloxone: Naloxone Use as Opioid Safety Measure
Showing all 4 trials